IP Library Granted Patent US 8,652,794
Granted Patent B2
US 8,652,794 · App. 13/023,704 · Granted Feb 18, 2014

Mutant luciferase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,794
App. No.
13/023,704
Granted
Feb 18, 2014
Kind
B2
Abstract

An isolated recombinant luciferase having luciferase activity. The recombinant luciferase has an amino acid sequence which differs from the wild-type luciferase from Photinus pyralis, Luciola mingrelica, Luciola cruciata, Luciola lateralis, Hotaria parvula, Pyrophorus plagiophthalamus, Lampyris noctiluca, Pyrocoelia miyako or Photinus pennsylvanica . In the sequence of the recombinant luciferase, the amino acid residue corresponding to phenylalanine 295 in Photinus pyralis wild-type luciferase or to leucine 297 in Luciola mingrelica, Luciola cruciata or Luciola lateralis wild-type luciferases, is mutated compared to the corresponding amino acid which appears in the corresponding wild-type luciferase sequence. The recombinant luciferase has increased thermostability compared to the corresponding wild-type luciferase.

Claims (15)

1. An isolated recombinant luciferase having luciferase activity and comprising a variant of wild-type Photinus pyralis luciferase of SEQ ID NO: 37, wherein the amino acid sequence of said recombinant luciferase has no more than 50 amino acid differences as compared to the amino acid sequence of SEQ ID NO: 37, wherein the amino acid residue of the recombinant luciferase corresponding to position 295 of SEQ ID NO:37 is leucine, the amino acid residue of the recombinant luciferase corresponding to position 214 of SEQ ID NO:37 is an amino acid residue other than threonine, the amino acid residue of the recombinant luciferase corresponding to position 232 of SEQ ID NO:37 is an amino acid residue other than isoleucine, and the amino acid residue of the recombinant luciferase corresponding to position 354 of SEQ ID NO:37 is an amino acid residue other than glutamic acid, and wherein the recombinant luciferase has increased thermostability as compared to the wild-type Photinus pyralis luciferase of SEQ ID NO:37.

2. The recombinant luciferase of claim 1 , further comprising an amino acid other than phenylalanine at the amino acid residue corresponding to position 14 of SEQ ID NO:37.

3. The recombinant luciferase of claim 2 , wherein the amino acid residue corresponding to position 14 of SEQ ID NO:37 is alanine.

4. The recombinant luciferase of claim 1 , further comprising an amino acid other than leucine at the amino acid residue corresponding to position 35 of SEQ ID NO:37.

5. The recombinant luciferase of claim 4 , wherein the amino acid residue corresponding to position 35 of SEQ ID NO:37 is alanine.

6. The recombinant luciferase of claim 1 , wherein the amino acid at the residue corresponding to position 354 of SEQ ID NO:37 is lysine.

7. The recombinant luciferase of claim 1 , further comprising an amino acid other than alanine at the amino acid residue corresponding to position 215 of SEQ ID NO:37.

8. The recombinant luciferase of claim 7 , wherein the amino acid residue corresponding to position 215 of SEQ ID NO:37 is lysine.

9. The recombinant luciferase of claim 1 , wherein the amino acid residue corresponding to position 214 of SEQ ID NO:37 is alanine, the amino acid residue corresponding to position 232 of SEQ ID NO:37 is alanine and the amino acid residue corresponding to position 354 of SEQ ID NO:37 is lysine.

10. The recombinant luciferase of claim 1 , further comprising an amino acid other than phenylalanine at the amino acid residue corresponding to position 14 of SEQ ID NO:37 and an amino acid other than leucine at the amino acid residue corresponding to position 35 of SEQ ID NO:37.

11. The recombinant luciferase of claim 10 , wherein the amino acid residue corresponding to position 14 of of SEQ ID NO:37 is alanine and the amino acid residue corresponding to position 35 of SEQ ID NO:37 is alanine.

12. The recombinant luciferase of claim 10 , further comprising an amino acid other than alanine at the amino acid residue corresponding to position 215 of SEQ ID NO:37.

13. The recombinant luciferase of claim 12 , wherein the amino acid residue corresponding to position 215 of SEQ ID NO:37 is leucine.

14. A bioluminescent assay comprising the steps of contacting the recombinant luciferase of claim 1 with luciferin and detecting bioluminescence.

15. A kit comprising the recombinant luciferase of claim 1 .

Assignments (4)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: SQUIRRELL, DAVID JAMES; MURPHY, MELENIE JANE; PRICE, RACHEL LOUISE; LOWE, CHRISTOPHER ROBIN; WHITE, PETER JOHN; TISI, LAURENCE CARLO; MURRAY, JAMES AUGUSTUS HENRY
To: THE SECRETARY OF STATE FOR DEFENCE
Reel/Frame 033213/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 033214/0014 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: 3M INNOVATIVE PROPERTIES COMPANY
To: PROMEGA CORPORATION
Reel/Frame 033214/0207 →